Bhatnagar Anish, CHIEF EXECUTIVE OFFICER at SOLENO THERAPEUTICS INC (SLNO), sold 41,322 shares at $46.18 ($1.9M) on 2025-01-03, disclosed to the SEC on 2025-01-06.
Seasonal sale ($1.9M) by CHIEF EXECUTIVE OFFICER — this insider has traded SLNO in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.37 | 10,077 | $457K | 24.2% |
| 2 | $45.37 | 10,077 | $457K | 24.2% |
| 3 | $45.92 | 860 | $39K | 2.1% |
| 4 | $46.18 | 10,154 | $469K | 24.8% |
| 5 | $46.18 | 10,154 | $469K | 24.8% |
| Total | $45.78 avg | 41,322 |
| $1.9M |
| 100% |
| Filing → |
| SLNO | SELL | 2024-08-30 | $10.9M | — | Filing → |
| SLNO | SELL | 2024-08-07 | $11.6M | — | Filing → |
| SLNO | SELL | 2024-07-03 | $1.6M | — | Filing → |